About NephroOncoGuides

Our Mission

Renal complications and acute kidney injury occur in up to 40% of cancer patients undergoing intensive chemotherapy, immunotherapy, or targeted therapy. NephroOncoGuides was established as an open-access public health resource to provide oncology teams, nephrologists, patients, and caregivers with evidence-based staging algorithms, chemoprotective protocols, and direct access to dialysis copay grants worldwide.

What We Provide

8 Clinical Disease Guides: In-depth breakdowns of Cisplatin ATN, High-Dose Methotrexate Crystalluria, Immune Checkpoint Inhibitor Nephritis, VEGF Glomerulopathy & TMA, Tumor Lysis Syndrome, Multiple Myeloma Cast Nephropathy, Ifosfamide Fanconi Syndrome, and Radiation Nephropathy.
KDIGO AKI & CKD-EPI 2021 eGFR Calculator: Validated calculation of race-free glomerular filtration rate and Stage 1-3 AKI severity.
Cairo-Bishop Tumor Lysis Syndrome (TLS) Scorer: Evaluation of laboratory and clinical TLS criteria with Rasburicase weight-based dosing.
Calvert Carboplatin AUC & Renal Dose Decoder: Precise dose computation with GFR capping ($125\text{ mL/min}$) and HD-MTX leucovorin rescue nomograms.
100+ Global Dialysis & Copay Grants: Vetted directory of non-profit foundations, US Medicare ESRD rules, and travel subsidies across 20+ countries.
Zero-Knowledge Patient Vault: Private local storage allowing patients to log serial renal labs without cloud tracking.

Part of the OncoGuides Network

NephroOncoGuides is part of the unified OncoGuides network, alongside human oncology (cancer.oncoguides.org), autoimmune diseases (autoimmune.oncoguides.org), psycho-oncology (psycho.oncoguides.org), cardio-oncology (cardio.oncoguides.org), neuro-oncology (neuro.oncoguides.org), and lymphedema (lymphedema.oncoguides.org).